- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 13.54M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $387.66M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $344.12M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $106.03M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $124.93M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $126.39M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $106.59M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $212.54M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $240.48M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $673.36M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $658.85M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $254.48M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $238.46M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $777.1M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $767.67M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.28M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.75M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $131.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $124.13M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $25.8M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $11.86M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.02M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.18M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $70.52M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $8.55M |
| Revenue | Q1 2025 · Mar 31, 2024 | $167.77M |